Atlas Trials

Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.

Clinical trial NCT04627753 · RECRUITING

Trial details

NCT number
NCT04627753
Sponsor
Kim, Seok Jin
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Primary CNS Lymphoma
Start date
2020-11-02
Primary completion
2028-11-02
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.